피플바이오

304840KOSDAQ

62.4 / 100

Reference Date: 2026-09-08

Financial Score22.0 / 40

News Sentiment20.4 / 25

Momentum10.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

PeopleBio is a biotech company specializing in the development of biomarker-based diagnostic technologies for early detection of Alzheimer's disease. The company's SI-MDS technology enables the detection of oligomeric beta-amyloid through blood tests, offering a cost-effective and efficient alternative to existing methods like PET or lumbar puncture. With rising demand for dementia diagnostics due to aging populations, the market is expected to grow significantly.

Number of Employees

43people

Average Salary

60.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.48Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-93.48Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

6.75Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼19.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲25.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -106.2% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 0Negative 1Average Sentiment Score 81.7

Negative
[기로의상장사]피플바이오①'깡통 부동산' 뻥튀기 인수로 사면초가
피플바이오의 깡통 부동산 고가 인수로 인해 재무 리스크가 증가하여 부정적인 영향이 예상됩니다.
Positive
피플바이오 ‘알츠온 플러스’, FDA 혁신의료기기 지정…美 진출 속도
피 PEOPLE바이오의 알츠하이머 조기진단 키트가 FDA로부터 혁신의료기기 지정을 받아 미국 시장 진출에 긍정적 영향을 미칠 것으로 예상됩니다.
Positive
피플바이오, 치매 진단 혈액키트 '알츠온 플러스' 美 혁신의료기기 지...
피 PEOPLE바이오의 알츠하이머병 조기진단 키트가 미국 FDA로부터 혁신의료기기 인증을 받아 주가 상승 기대.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 561Won52-week high 2,01552-week low 561

1-month return3.0Point

1m 0% (flat)

Volume trend6.0Point

Volume surge

Detailed Disclosure

8 totalPositive 0Neutral 8Negative 0

Neutral[기재정정]타인에대한담보제공결정2026-08-25
Neutral[기재정정]타인에대한담보제공결정2026-08-25
Neutral[기재정정]주식병합결정2026-08-24
Neutral[첨부정정]주요사항보고서(유형자산양수결정)2026-08-18
Neutral단기차입금증가결정2026-08-14